Selecta Biosciences, Inc.
7 clinical trials · Sponsor
◉ Watch Selecta Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy (NCT03905512) | Selecta Biosciences, Inc. | 2019-05-07 |
Track Selecta Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.